Bcr-Abl inhibitor CHMFL-ABL-121, Purity ≥98%

Synonym: 2270879-07-5; Bcr-Abl inhibitor

Product Size

1 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CHMFL-ABL-121 specifically inhibits the activity of the Bcr-Abl tyrosine kinase. It targets ABL wt and ABL-T315I.

Molecular Weight

580.67

Molecular Formula

C₃₀H₃₁F₃N₆OS

Targets

ABL wt: 2 nM; ABL-T315I: 0.2 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

CHMFL-ABL-121 targets the Bcr-Abl fusion kinase, providing insights for developing treatments for leukemia.